Over 29.10 crore Covid vaccine doses provided to States/UTs: Centre

More than 3.06 crore (3,06,34,638) Covid vaccine doses are still available with the States/UTs to be administered.

Coronavirus vaccine, Covid-19 vaccine, Covid vaccine
Photo: Shutterstock
ANI General News
2 min read Last Updated : Jun 20 2021 | 11:55 AM IST

More than 29.10 crore (29,10,54,050) vaccine doses have been provided to States ad Union Territories so far by the central government (free of cost channel) and through direct state procurement category, the Union Health Ministry said.

The total consumption, including wastages is 26,04,19,412 doses, as per data available at 8 AM on Sunday.

More than 3.06 crore (3,06,34,638) COVID vaccine doses are still available with the States/UTs to be administered.

Furthermore, more than 24,53,080 vaccine doses are in the pipeline and will be received by the States/UTs within the next three days.

As part of its nationwide vaccination drive, the central government has been supporting the States and UTs by providing them COVID vaccines free of cost.

In addition, the central government has also been facilitating direct procurement of vaccines by the States/UTs.

Vaccination is an integral pillar of the comprehensive strategy of government of India for containment and management of the pandemic, along with test, track, treat and COVID appropriate behaviour.

The implementation of the Liberalized and Accelerated Phase-3 Strategy of Covid-19 vaccination started from May 1, 2021.

Under the strategy, in every month 50 per cent of the total Central Drugs Laboratory (CDL) cleared vaccine doses of any manufacturer would be procured by central government.

It would continue to make these doses available to the state governments totally free of cost as was being done earlier.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusLockdownVaccineVaccinationCoronavirus TestsCoronavirus VaccineHealth Ministry

First Published: Jun 20 2021 | 11:55 AM IST

Next Story